Animal & Veterinary 27
- Circumstances that Constitute Delaying, Denying, Limiting, or Refusing a Drug or Device Inspection
- Bioresearch Monitoring Program Inspections: Processes and Procedures for Site Evaluations (DRAFT)
- Remote Regulatory Assessments for FDA-Regulated Products and Establishments (DRAFT)
- Translation of Non-English Good Laboratory Practice (GLP) Study Reports (DRAFT)
- Histopathology Peer Review in Nonclinical Toxicology Studies
- Export Certification Process and Requirements for FDA-Regulated Products
- Technical Considerations for Nitinol-Containing Medical Devices
- Certificates of Confidentiality for Non-Federally Funded Research: Protection of Human Subject Privacy in FDA-Regulated Studies
- Product Recalls, Removals, and Corrections: Procedures and Best Practices
- Release of Laboratory Test Results to Responsible Parties Without Freedom of Information Act Requests
- Public Warning and Notification of Recalls Under Part 7
- Medical Product Communications That Are Consistent With FDA-Required Labeling
- Recommendations for Labeling Medical Products Without Natural Rubber Latex
- Considering Whether FDA-Regulated Products Involve Nanotechnology
- Public Disclosure of Advisory Committee Members' Financial Interests and Waivers
- Public Participation in Open Public Hearing Sessions of Advisory Committee Meetings
- Voting Procedures for Advisory Committee Meetings
- Preparation and Submission of Advisory Committee Briefing Materials for Public Release
- Container and Closure System Integrity Testing as an Alternative to Sterility Testing for Stability Protocols
- Electronic Distribution of Product Information and Safety Communications
- Electronic Records and Electronic Signatures - Scope and Application
- Industry-Supported Scientific and Educational Activities: Maintaining Independence from Promotional Influence
- Direct Final Rulemaking Procedures and Implementation Process
- Maintaining Independence of Industry-Supported Scientific and Educational Activities
- Export Requirements for Products Not Approved for Sale in the United States
- Reinspection of Firms During Pending Legal Actions
- Good Laboratory Practice (GLP) Requirements for Non-Clinical Laboratory Studies